Development and validation of liquid chromatography method for determination of glimepiride in presence of (Vimto®) soft drinks in rats: application to pharmacokinetics studies
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Medknow in Journal of Pharmacy and Bioallied Sciences
- Vol. 11 (1) , 49-59
Abstract
Context: Diet and beverages are thought to have notable effects on drugs. Recently, this relationship has received significant consideration. Aims: To develop and validate a simple, rapid, and sensitive method for the determination of glimepiride in rat serum. This will be performed using high-performance liquid chromatography–mass spectrometry (HPLC-MS/MS). Potential pharmacokinetic interactions between glimepiride and the soft drink, Vimto, will also be investigated in the serum of experimental rats. Materials and Methods: HPLC-MS/MS was constructed and clarithromycin was used as an internal standard. Results: The method was validated in terms of linearity, precision, accuracy, stability, and system suitability parameters. The method was found to be satisfactory and suitable for the determination of glimepiride. The precision of glimepiride was high (coefficient of variation, CV% Cmax) was 126.01ng/mL and was reached within 1h (Tmax) of administration. Mean area under curve (AUC) was 964.70ng/mL and was reached within 24h of administration. The Vimto soft drink significantly (P < 0.050) reduced glimepiride peak serum concentration to 57.87ng/mL and was reached within 2h of administration. AUC was significantly reduced to 335.04 ng*h/mL (P < 0.050). Conclusion: Glimepiride pharmacokinetic parameters such as Cmax and AUC were significantly affected by the Vimto soft drink. Therefore, this study developed a simple, rapid, and sensitive method for validation and determination of the effects of soft drinks on drugs using the LC-MS/MS method.Keywords
This publication has 12 references indexed in Scilit:
- Effects of Food Intake on the Pharmacokinetic Properties of Mirabegron Oral Controlled-Absorption System: A Single-Dose, Randomized, Crossover Study in Healthy AdultsClinical Therapeutics, 2013
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Selecting an Appropriate Medication for Treating Neuropathic Pain in Patients with Diabetes: A Study Using the U.K. and Germany Mediplus DatabasesPain Practice, 2008
- Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamideBritish Journal of Clinical Pharmacology, 2007
- Pharmacokinetics and Pharmacodynamics of Glimepiride in Type 2 Diabetic Patients: Compared Effects of Once- versus Twice-daily DosingEndocrine Journal, 2007
- Diabetes mellitus: complications and therapeutics.2006
- Development of a rapid method for the determination of glimepiride in human plasma using liquid‐liquid extraction based on 96‐well format micro‐tubes and liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2005
- Drug-nutrient interaction in clinical nutritionCurrent Opinion in Clinical Nutrition and Metabolic Care, 2002
- Clinical review of glimepirideExpert Opinion on Pharmacotherapy, 2001
- Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.1994